RT @suvash: It’s been a pretty intense couple of days of learning at #ASMNGS18 ! So much to take in, and huge thank… https://t.co/gsuNUkLiB1
4:05pm September 26th 2018 via Hootsuite Inc.
RT @KayBFX: Fantastic talk by @ivanliachko including early data of Hi-C from @PhaseGenomics plus SMRT sequence from… https://t.co/aL7HTVGd6Z
3:35pm September 26th 2018 via Hootsuite Inc.
RT @lifebitAI: Your #DNA Is Not Your Culture! #genomics #bigdata @TheAtlantic https://t.co/O5ydbstvrd https://t.co/07BJQKqeHG
2:45pm September 26th 2018 via Hootsuite Inc.
A piece about https://t.co/Qu9sNiPMZj RT @GenomicsPlaza: Blockchain Genomics Startup Allows You To Make Money With… https://t.co/2tiAiizEUT
1:40pm September 26th 2018 via Hootsuite Inc.
Imfinzi is the first immunotherapy to demonstrate significant overall survival benefit in unresectable, Stage III l… https://t.co/EiVRN65KQ0
12:27pm September 26th 2018 via Hootsuite Inc.
RT @pavitrarc: .@torstenseemann describes a bioinformatician's average Tuesday #ASMNGS18 https://t.co/LidFIAYXFl
11:35am September 26th 2018 via Hootsuite Inc.
The end of HIV transmission in the U.S.: A once-thinkable dream becomes an openly discussed goal | Stat News https://t.co/021p7U2INW
10:30am September 26th 2018 via Hootsuite Inc.
A Deeper Dive into the BioHealth Capital Region’s #4 Spot on GEN’s Top 10 U.S. Biopharma Clusters List | BioBuzz https://t.co/P0yAEGXJhw
9:19am September 26th 2018 via Hootsuite Inc.
RT @gottfriedjeff: NEW: Just 4% of Americans have a lot of trust in the information they get from social media.… https://t.co/BHTtW78OwC
2:30pm September 25th 2018 via Hootsuite Inc.
Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA |… https://t.co/bFTFlkuaB3
1:30pm September 25th 2018 via Hootsuite Inc.
ICYMI New Post: The value proposition of precision oncology requires careful education - Pillar Biosciences Blog https://t.co/hlSfkzabDT
12:16pm September 25th 2018 via Hootsuite Inc.
New Post: The value proposition of precision oncology requires careful education - Pillar Biosciences Blog https://t.co/hlSfkzabDT
4:45pm September 24th 2018 via Hootsuite Inc.
"Every time I diagnose colorectal cancer, I feel like the system has failed." | Stat News https://t.co/7dT7wvofyx
Have you heard of the Brave Browser? The Crypto Project that is Disrupting a $300 Billion Industry | Medium https://t.co/0e6M4W8vMT
3:30pm September 24th 2018 via Hootsuite Inc.
Speeches by FDA Officials > Blueprint for Breakthroughs - Charting the Course for Precision Medicine | FDA Gottlieb… https://t.co/9lgQ9gq
11:05am September 17th 2018 via Hootsuite Inc.
Cancer Spreads from Organ Donor to Four People in ‘Extraordinary’ Case | Live Science https://t.co/jPOQRWNyfo
10:30am September 17th 2018 via Hootsuite Inc.
How nucleic acid memory could be used to store data in DNA | VentureBeat #longread https://t.co/B4yUzhm8R0
9:25am September 17th 2018 via Hootsuite Inc.
ICYMI: David Altshuler at #AGBTph18: Diverse Perspectives on Genomic Medicine - Pillar Biosciences https://t.co/Un1a1KmeIH
8:05am September 17th 2018 via Hootsuite Inc.
What really defines wisdom in the workplace - an example from AirBnB | Fast Company https://t.co/SQIgx8bB7i
7:05am September 17th 2018 via Hootsuite Inc.
@ctitusbrown @FastMail When I decided to get out of the 'Goolag' I have been a happy @fastmail customer now for over a year. Well worth it.
4:03pm September 16th 2018 via Hootsuite Inc. in reply to ctitusbrown
New Post: David Altshuler at #AGBTph18: Diverse Perspectives on Genomic Medicine - Pillar Biosciences https://t.co/Un1a1KmeIH
10:41am September 14th 2018 via Hootsuite Inc.
UCLA scientist shares 2018 Lasker Prize for figuring out how genes turn on and off | LA Times https://t.co/A2Qb6HcShf
10:35pm September 11th 2018 via Hootsuite Inc.
Great Pacific Garbage Patch Plastic Collector Set to Launch | Nat'l Geographic https://t.co/8A6pr3h5Y2
3:15pm September 11th 2018 via Hootsuite Inc.
Pivotal CRISPR patent battle won by Broad Institute | Nature News https://t.co/iNhxX0biU4
2:02pm September 11th 2018 via Hootsuite Inc.
Quantapore Working Towards Commercialization of Optical Nanopore Sequencing Tech | GenomeWeb ($) https://t.co/vqTRSdBycL
11:36am September 5th 2018 via Hootsuite Inc.
Radical open-access plan could spell end to journal subscriptions | Nature https://t.co/AEMimT6z4b
10:40am September 5th 2018 via Hootsuite Inc.
10x Genomics Acquires Epinomics | GenomeWeb https://t.co/rq5BNEvQ0O
3:24pm August 28th 2018 via Hootsuite Inc.
Illumina Secures China National Drug Administration Clearance for MiSeqDx System | GenomeWeb https://t.co/fqUVN2ICis
2:44pm August 28th 2018 via Hootsuite Inc.
A CRISPR cure for Duchenne muscular dystrophy is closer after a trial in dogs - MIT Technology Review https://t.co/0vM9fV7qSa
6:55am August 27th 2018 via Hootsuite Inc.
Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay | GenomeWeb https://t.co/lU4fbBEVKK
10:05am August 24th 2018 via Hootsuite Inc.
This ancient bone belonged to a child of two extinct human species | Science Magazine https://t.co/aMd0UNJxrn
8:25pm August 22nd 2018 via Hootsuite Inc.
Bionano Genomics Raises $20.6M in IPO, Starts Trading on Nasdaq | GenomeWeb https://t.co/yrNuDDdNWs
6:50pm August 22nd 2018 via Hootsuite Inc.
Consumer genomics will change your life, whether you get tested or not | Genome Biology https://t.co/7Aji5ZvxI7
8:15pm August 20th 2018 via Hootsuite Inc.
Bresler #NGDx18 Don't forget about the science in the IVD: one of their customers had a reagent stable at 4C for 2y… https://t.co/FXCWbSFlY6
2:57pm August 20th 2018 via Hootsuite Inc.
Lek: #NGDx18 Mokol did his post-doc at Broad, last year has been at Yale increasing Dx yield for rare neuro disease.
1:40pm August 20th 2018 via Hootsuite Inc.
Lek: #NGDx18 Intro remarks on speaker lineup - MSKCC for clinical decision support in oncology, UPMC for Cloud WGS… https://t.co/IYlMkKt7av
Lek: #NGDx18 Beyond sequencing: functional genomics, machine learning, and adv analytics
1:36pm August 20th 2018 via Hootsuite Inc.
Here at #NGDx18 https://t.co/hAp6T8nVdO and will be live-tweeting; first up Mokol Lek (Yale SOM) NGS Data Analysis for Inh Disease.
1:34pm August 20th 2018 via Hootsuite Inc.
MT @BluebeeGenomics: Naomi Thomson, Bluebee’s Dir of Biz Dev, is off to #NGDx18. DM or email info@bluebee.com to ar… https://t.co/fyaX2NXAbK
1:31pm August 20th 2018 via Hootsuite Inc.
https://t.co/kcnCjW5IHz Check out their interesting tech if you attend #NGDx18 - and look for @Pillar_Bio too!
1:22pm August 20th 2018 via Hootsuite Inc.
Review of sequencing technologies by generation and instruments https://t.co/ccy6sCEC9p
11:44am August 18th 2018 via Hootsuite Inc.
From Juggling to Biomechanics – NIH Director's Blog https://t.co/D1ZUr1bRrn
11:01am August 14th 2018 via Hootsuite Inc.
Large-Scale Proteomic Analysis Indicates Potential of Circulating Proteome for Biomarker Work | GenomeWeb https://t.co/vU6tOT2bUE
8:41am August 14th 2018 via Hootsuite Inc.
Study finds Tdap vaccination for pregnant women does not increase risk of autism | EurekAlert! Science News https://t.co/bzZda5PFY3
9:45am August 13th 2018 via Hootsuite Inc.
Cancer: one in four too scared to seek medical help over symptoms | MSN https://t.co/f1UTCZbGI9
7:25am August 13th 2018 via Hootsuite Inc.
DNA ancestry tests may look cheap. But your data is the price | The Guardian https://t.co/1YVkApRDVh
6:40am August 13th 2018 via Hootsuite Inc.
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology | Oncology | JAMA O… https://t.co/MheO0Furjz
7:10am August 10th 2018 via Hootsuite Inc.
Geisinger Team Describes Approach for Returning Secondary Genomic Findings to Research Participants | GenomeWeb https://t.co/Eh5hdAJTur
4:30pm August 9th 2018 via Hootsuite Inc.
Researchers Integrate Genotyping Assay, Drug Delivery Tech for Precision Glioma Treatment | GenomeWeb ($) https://t.co/YJXZAG6bEP
3:16pm August 9th 2018 via Hootsuite Inc.
RT @DaleYuzuki: New Post: How does AmpliSeq NGS enrichment compare to Pillar Biosciences SLIMamp? - Pillar Biosciences Blog https://t.co/HU…
7:18am August 9th 2018 via Hootsuite Inc.
